Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
GCM Grosvenor
GCMG
$2.82B
| $7.99M | ﹤0.01% |
693,965
+80,664
| +13% | +$875K |
|
2627
Independent Bank Corp
IBCP
$854M
| $7.99M | ﹤0.01% |
371,903
-2,552
| -0.7% | -$53.1K |
|
2628
Erasca
ERAS
$6.25B
| $7.99M | ﹤0.01% |
+376,320
| New | +$7.76M |
|
2629
Transcat
TRNS
$888M
| $7.98M | ﹤0.01% |
123,787
+730
| +0.6% | +$46.6K |
|
2630
Digimarc Corp
DMRC
$167M
| $7.94M | ﹤0.01% |
230,544
+939
| +0.4% | +$27.7K |
|
|
AGTI
2631
DELISTED
Agiliti Inc
AGTI
| $7.93M | ﹤0.01% |
416,420
+7,422
| +2% | +$149K |
|
2632
Ennis
EBF
$556M
| $7.92M | ﹤0.01% |
420,466
-12,982
| -3% | -$255K |
|
2633
Aldeyra Therapeutics
ALDX
$91.7M
| $7.92M | ﹤0.01% |
901,917
+3,400
| +0.4% | +$31.2K |
|
|
TRUE
2634
DELISTED
TrueCar
TRUE
| $7.92M | ﹤0.01% |
1,902,678
+51,469
| +3% | +$239K |
|
2635
CVR Energy
CVI
$3.52B
| $7.91M | ﹤0.01% |
475,086
-6,309
| -1% | -$89K |
|
2636
Annexon
ANNX
$862M
| $7.91M | ﹤0.01% |
425,043
+19,311
| +5% | +$392K |
|
|
KDNY
2637
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $7.91M | ﹤0.01% |
619,769
+1,063
| +0.2% | +$14K |
|
2638
Funko
FNKO
$331M
| $7.89M | ﹤0.01% |
433,551
+15,529
| +4% | +$293K |
|
|
SFT
2639
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $7.89M | ﹤0.01% |
113,690
+5,089
| +5% | +$408K |
|
2640
Lyell Immunopharma
LYEL
$347M
| $7.87M | ﹤0.01% |
26,594
+17,873
| +205% | +$5.36M |
|
2641
Nkarta
NKTX
$165M
| $7.84M | ﹤0.01% |
281,910
-9,165
| -3% | -$290K |
|
2642
Scorpio Tankers
STNG
$3.81B
| $7.82M | ﹤0.01% |
421,873
+38,824
| +10% | +$648K |
|
2643
Precigen
PGEN
$2.32B
| $7.82M | ﹤0.01% |
1,566,286
-259,149
| -14% | -$1.49M |
|
2644
Gulfport Energy Corp
GPOR
$3.01B
| $7.81M | ﹤0.01% |
+94,996
| New | +$6.61M |
|
|
AKTS
2645
DELISTED
Akoustis Technologies Inc
AKTS
| $7.8M | ﹤0.01% |
803,999
+68,290
| +9% | +$655K |
|
2646
Prelude Therapeutics
PRLD
$428M
| $7.79M | ﹤0.01% |
249,172
+25,920
| +12% | +$839K |
|
2647
Stagwell
STGW
$2.28B
| $7.79M | ﹤0.01% |
1,015,096
-65,723
| -6% | -$438K |
|
|
AMK
2648
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $7.76M | ﹤0.01% |
312,177
+7,005
| +2% | +$181K |
|
|
KNTE
2649
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $7.76M | ﹤0.01% |
337,222
+99,973
| +42% | +$2.18M |
|
|
HCCI
2650
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $7.76M | ﹤0.01% |
267,701
+4,278
| +2% | +$122K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.